Skip to content
Question
What will a month cost?
What it costs
$199/mo
Read
6 min
Published
September 2026

PT 141 Cost: Bremelanotide Is Priced by the Dose, and Rarely Published

Bremelanotide is sold by the single-dose pen, capped at eight doses a month by its label, and most sellers that list it publish no price at all.

ByDerek MossPricing analystPublished

PT-141 has no public monthly price on this roster. The count below is live. It compares sellers that list the drug with sellers that print a figure on the price boards.

80

Sellers on our roster that list PT-141

33

Of those, sellers that publish a monthly price

8

Most doses per month the Vyleesi label recommends

Source: Vyleesi label

Across 28 sellers that publish one, a month typically costs $199. The range runs from $73 to $328.

What you are pricing

PT-141 is the research name for bremelanotide. The approved product is Vyleesi, a 1.75 mg single-dose autoinjector[1]. It ships in cartons of 2 or 4 pens[1].

That packaging sets the unit. You buy doses. A monthly cost is doses used times the price per dose. The same arithmetic applies to any peptide therapy cost.

The label sets the ceiling. No more than one dose in 24 hours[1]. More than 8 doses a month is not recommended[1]. So the most a label-following month can cost is eight doses.

Who the label covers

Vyleesi is indicated for premenopausal women with acquired, generalized hypoactive sexual desire disorder[1]. It is not indicated for postmenopausal women or for men[1]. It is not indicated to enhance sexual performance[1].

That matters for cost. A prescription outside the label is off-label. A plan is less likely to pay for it.

Why insurance rarely helps

Medicare Part D has a statutory carve-out. A drug used for sexual or erectile dysfunction is not a covered Part D drug[4]. The exception is a drug used for another condition it is approved for[4].

Private plans set their own formularies. Check yours before paying cash. The insurance guide covers the general rules.

What the trials found

Two phase 3 trials, called RECONNECT, randomized 1,267 premenopausal women[2]. Treatment ran 24 weeks, dosed as needed[2].

Desire scores rose 0.35 points more than placebo in the integrated analysis[2]. Distress scores fell 0.33 points more[2]. Nausea, flushing and headache hit 10% or more in both trials[2].

The label adds a stop rule. Discontinue after 8 weeks if symptoms have not improved[1]. Budget for eight weeks before judging the spend.

Compounded PT-141

Compounding telehealths list bremelanotide too. Their price usually appears after the intake. Ask three things before paying.

  • Is the price per dose, per vial, or per month?
  • How many doses does one vial hold at the prescribed dose?
  • Is the consult billed separately from the drug?

A compounded product is not the approved product. Who compounds it, and under which rules, is set out in 503A vs 503B.

When a seller publishes a figure, it reaches the boards. Reviewed sellers are on the reviews page.

FAQ

4 questions

How much does PT-141 cost?

The brand, Vyleesi, is sold per single-dose pen, so a month costs the number of doses used times the per-dose price. Most compounding sellers that list PT-141 publish no price before the intake.

How many doses of PT-141 can be used in a month?

The Vyleesi label says no more than one dose in 24 hours, and more than 8 doses a month is not recommended.

Does Medicare cover PT-141?

Part D excludes drugs used for sexual or erectile dysfunction by statute, unless the drug is used for another condition it is approved for.

Is PT-141 approved for men?

No. The Vyleesi label states it is not indicated for men or for postmenopausal women.

Sources

4 cited
  1. [1]Cosette Pharmaceuticals, Inc. (2025). VYLEESI (bremelanotide) injection, for subcutaneous use: Prescribing Information DailyMed, U.S. National Library of Medicine. Source
  2. [2]Kingsberg SA, Clayton AH, Portman D, et al. (2019). Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials Obstetrics and Gynecology. PMID 31599840
  3. [3]Spielmans GI, Ellefson EM (2024). Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder Journal of Sex Research. PMID 36809187
  4. [4]United States Code (2024). 42 U.S.C. 1395w-102(e), Covered part D drug defined Office of the Law Revision Counsel. Source

Where to buy PT-141 (bremelanotide)

Lowest injection prices
  1. 1ImmortalsPriced, not reviewed$73/moGet price →
  2. 2EOS HealthPriced, not reviewed$135.20/moGet price →
  3. 3Bodybuilding Health+Priced, not reviewed$169/moGet price →

Medication price as each seller publishes it, before fees. The full PT-141 (bremelanotide) price board